Trials / Completed
CompletedNCT04727775
Antiviral Drugs on the Treatment of SARS-CoV-2
A Retrospective Study of the Effect of Antiviral Drugs on the Treatment of SARS-CoV-2 COVID19
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (actual)
- Sponsor
- Astana Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Retrospective Non-Randomized Analytical Cohort Study of Completed SARS-CoV2 COVID19 Cases
Detailed description
Analyzing the case histories of patients with SARS-CoV2 COVID19 infection and the impact on the outcomes of prescribing antiviral drugs
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Favipiravir | Antiviral drugs |
| DRUG | Remdesivir | Antiviral drugs |
Timeline
- Start date
- 2020-12-01
- Primary completion
- 2023-07-25
- Completion
- 2023-07-25
- First posted
- 2021-01-27
- Last updated
- 2023-08-02
Locations
2 sites across 1 country: Kazakhstan
Source: ClinicalTrials.gov record NCT04727775. Inclusion in this directory is not an endorsement.